Bang Wool Eom
Goyang-si, Gyeonggi-do, 10408, South Korea
NCT Number: NCT04394585
This study is a single center, prospective, randomized controlled study. The aim of this study is to evaluate the effect of smart phone app-based human coaching program on QOL in patients who underwent gastrectomy for stage I gastric cancer. The hypothesis of this study is the patients who used smart phone app-based human coaching program for three months after surgery will have better QOL than patients who did not use it. The QOL will be assessed using EORTC QLQ C30 and STO22 at 3 months postoperatively. The secondary endpoints are QOL at 6 months postoperatively, 12 months postoperative, food intake, body composition, and nutritional indicators from blood test.
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Not applicable
Goyang-si, Gyeonggi-do, 10408, South Korea
< Patient enrollment>
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 month postoperatively
Eating resection scale is calculated according to the following equation. a. Add questionnaire items 41,42, 43 and 46 and divide this sum by the number of items (4): EatR = (Q41+Q42+Q43+Q46)/4 b. Carry out a linear transformation to convert to a 1-100 scale: XEatR = (EatR-1)*100/3 The 4 items are belong to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) STO22. Each item has a value among 1, 2, 3, and 4 according to the answer and the scale score has a value ranging 0 (minimum) to 100 (maximum). Higher scores mean having more symptom and worse quality of life.
Time frame: 3 months postoperatively
Eating resection scale is calcuated according to the following equation.
EatR = (Q41+Q42+Q43+Q46)/4
XEatR = (EatR-1)*100/3
The 4 items are belong to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) STO22.
Each item has a value among 1, 2, 3, and 4 according to the answer and the scale score has a value ranging 0 (minimum) to 100 (maximum).
Higher scores mean having more symptom and worse quality of life.
Time frame: 6 months postoperatively
Eating resection scale is calcuated according to the following equation.
EatR = (Q41+Q42+Q43+Q46)/4
XEatR = (EatR-1)*100/3
The 4 items are belong to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) STO22.
Each item has a value among 1, 2, 3, and 4 according to the answer and the scale score has a value ranging 0 (minimum) to 100 (maximum).
Higher scores mean having more symptom and worse quality of life.
Time frame: 12 months postoperatively
Eating resection scale is calcuated according to the following equation.
EatR = (Q41+Q42+Q43+Q46)/4
XEatR = (EatR-1)*100/3
The 4 items are belong to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) STO22.
Each item has a value among 1, 2, 3, and 4 according to the answer and the scale score has a value ranging 0 (minimum) to 100 (maximum).
Higher scores mean having more symptom and worse quality of life.
Time frame: discharge day: up to 3 weeks postoperatively,1 month postoperatively
difference of food amount between discharge day and postoperative 1 month
Time frame: 3 months postoperatively
patient's weight in kilograms
Time frame: 3 months postoperatively
g/dL
Time frame: 3 months postoperatively
g/dL
Time frame: 3 months postoperatively
g/dL
Time frame: 3 months postoperatively
g/dL
National Cancer Center, Korea
Other Gov
A Study Evaluating Effect of Smart Phone App-based Human Coaching Program on QOL in Patients Who Underwent Gastrectomy for Stage I Gastric Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04454476
Digestive System Diseases, Digestive System Neoplasms
Nagasaki, Japan
View Trial DetailsNCT00183898
Digestive System Diseases, Digestive System Neoplasms
Los Angeles, California, United States
View Trial DetailsNCT00342654
Digestive System Diseases, Digestive System Neoplasms
Beijing, China
View Trial DetailsNCT05396300
Colonic Diseases, Colorectal Cancer
Hangzhou, Zhejiang, China
View Trial Details